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Abstract
Neuroinflammatory processes in the brain are believed to play a crucial role in the develop-
ment of neurodegenerative diseases, especially due to increased production of reactive oxy-
gen species. The brain is susceptible to oxidative stress more than other organs due to the low 
activity of antioxidant defense systems. In agreement with these observations, increased oxi-
dative stress plays an important role in the pathogenesis of neurodegenerative diseases such 
as Alzheimer disease, Parkinson disease, ischemic diseases and aging. The Mediterranean 
diet is inspired by the traditional dietary pattern of some countries of the Mediterranean 
basin. From ancient times, these populations were characterized by simple food habits as 
high intake of whole cereals (pasta, bread, rice), fruits and vegetables (up to 400 g day−1 
in Greece), legumes and fish, olive oil as the common source of fats, poor intake of meat 
and dairy products and a moderate, regular wine drinking. In the present chapter, there are 
going to be presented some bioactive substances present in the Mediterranean diet related to 
the prevention of neurodegenerative diseases. These substances are able to exert important 
antioxidant activity (through mechanisms such as sequestration of free radicals, inhibition of 
the production of hydrogen peroxide, activation of endogenous defense mechanisms.
Keywords: Mediterranean diet, neurodegenerative diseases, Alzheimer disease, 
Parkinson disease, melatonin, hydroxytyrosol
1. Introduction
Neurodegeneration in Parkinson’s, Alzheimer disease, and other neurodegenerative diseases 
seems to be multifactorial, in that a complex set of toxic reactions leads to the demise of 
neurons. Complications include: inflammation, glutamatergic neurotoxicity, increases in iron 
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and nitric oxide, depletion of endogenous antioxidants, reduced expression of trophic factors, 
dysfunction of the ubiquitin-proteasome system, and expression of proapoptotic proteins 
leads to the demise of neurons [1].
At pathological level, almost all neurodegenerative diseases share common features such as the 
generation of misfolded protein deposits, metal ion deregulation, and exposure to oxidative 
stress [2, 3]. In Alzheimer disease the extracellular senile plaques are consisted on amyloid-β 
peptides derived from the mutations in genes encoding the amyloid precursor protein while the 
intracellular tangles are from hyperphosphorylated Tau protein. In Parkinson disease the accu-
mulation of intracytoplasmic Lewy bodies is mainly composed of α-synuclein and ubiquitin [4].
Alzheimer’s disease is responsible of 70% cases of dementia in elderly people. Between 
2000 and 2013, United States of America death rates for dementia increased 21% for men 
and 31% for women. Among individuals 85 age old or older, dementia-associated death 
rates for women and men were ~4% and 3.2%, respectively [5]. Risk factors include hyper-
cholesterolemia, obesity, diabetes, and cardiovascular factors, such as hypertension, and 
inflammation [6].
Nowadays, neurodegenerative diseases are not curable and treatments have limited effective-
ness. Hence, increasing interest for effective preventive measures has been recently shown in 
the scientific literature [7]. Prevention of neurodegenerative diseases and search for new drugs 
are the great challenges of scientific research, because the symptoms appear in the human being 
only when the degeneration is advanced. Mechanisms involved in neurodegenerative diseases 
are complex and multifactorial. However, these mechanisms present common pathways, 
including: mitochondrial dysfunction, intracellular Ca2+ overload, oxidative stress and inflam-
mation. Often multiple pathways coexist, restricting benefits from therapeutic interventions.
Neuroinflammatory processes in the brain are believed to play a crucial role in the develop-
ment of neurodegenerative diseases, especially due to increased production of reactive oxy-
gen species. The brain is susceptible to oxidative stress more than other organs due to the 
low activity of antioxidant defense systems. In agreement with these observations, increased 
oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases 
such as Alzheimer disease, Parkinson disease, ischemic diseases and aging [8].
Several models of diet have been proposed but, until now, the highest attention of research-
ers, clinicians, and institutions has been focused on the Mediterranean diet. This diet has been 
promoted as a model for healthy eating and it has been widely recognized to have favorable 
effects on lipid profile and to provide a significant source of antioxidants and vitamins [9].
The Mediterranean diet is inspired by the traditional dietary pattern of some countries of the 
Mediterranean basin. From ancient times, these populations were characterized by simple food 
habits as high intake of whole cereals (pasta, bread, rice), fruits and vegetables (up to 400 g day−1 
in Greece), legumes and fish, olive oil as the common source of fats, poor intake of meat and 
dairy products and a moderate, regular wine drinking. The intake of saturated animal fats is rel-
atively low, and moderate fish consumption gives enough polyunsaturated fatty acids [9, 10].
Valls-Pedret et al. and Ngandu et al. provide a strong level of scientific evidence for the beneficial 
effects of the Mediterranean diet on cognitive functions [11, 12]. Several clinical, epidemiologi-
cal and experimental studies suggest that consumption of the Mediterranean diet reduces the 
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incidence of certain pathologies related to oxidative stress, chronic inflammation and immune 
system diseases such as cancer, atherosclerosis, cardiovascular disease and neurodegenerative 
diseases [13]. These reductions can be partially attributed to different bioactive compounds pres-
ent in the Mediterranean diet (omega 3 fatty acids, polyphenols, resveratrol or melatonin). In 
fact, the five most important adaptations induced by the Mediterranean dietary pattern are [7]:
1. Lipid lowering effect,
2. Protection against oxidative stress, inflammation and platelet aggregation,
3. Modification of hormones and growth factors involved in the pathogenesis of cancer,
4. Inhibition of nutrient sensing pathways by specific amino acid restriction, and
5. Gut microbiota-mediated production of metabolites influencing metabolic health.
There is negative correlation between cognitive functions, saturated fatty acids and protective 
effect against cognitive decline with increased fish consumption, high intake of monounsatu-
rated fatty acids and polyunsaturated fatty acids (PUFA), particularly n-3 PUFA [14]. Similarly, 
polyunsaturated and omega-3 fatty acids as docosahexaenoic acid (DHA) and eicosapentaenoic 
acid (EPA) supplements are associated with increased cognitive function, due to the cumulat-
ing of factors that ultimately favor membrane permeability and neuronal functioning [15].
There are numerous epidemiological studies relating the Mediterranean diet with the preven-
tion of neurodegenerative diseases and minor cognitive decline [14, 16]. However, other studies 
did not observe such relationship. Anastasiou et al. suggest that adherence to the Mediterranean 
diet is associated with better cognitive performance and reduced dementia in Greek elderly 
population [17]. Hardman et al. demonstrate that the relationship between Mediterranean diet 
score and cognition was only significant when medication use was taken into account.
In the present chapter, there are going to be presented some bioactive substances present in the 
Mediterranean diet related to the prevention of neurodegenerative diseases. These substances are 
able to exert important antioxidant activity (through mechanisms such as sequestration of free 
radicals, inhibition of the production of hydrogen peroxide, activation of endogenous defense 
mechanisms (catalase, superoxide dismutase), chelation of metals, etc.). However, many other 
biologically plausible mechanisms may be responsible for their protective effect [18, 19] as follows:
• Modulation of gene expression.
• Detoxification of carcinogens.
• Induction of cell death.
• Protection of DNA.
• Modification of cellular communication.
• Modification of the hormonal profile.
• Modulation of the lipid profile.
• Stimulation of the immune system.
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• Anti-inflammatory effect.
• Effects on hemostasis.
• Hypocholesterolemic effect.
• Hypotensive effect.
• Antimicrobial activity
2. Bioactive substances in the Mediterranean diet
2.1. Resveratrol
Resveratrol belongs to the family of stilbenes and is one of the most studied polyphenols, 
mostly present in grapes and wines. This stilbene was discovered in 1940 in Veratrum grandi-
florum by Takaoka [20] and reported in high concentration in Vitis vinifera in 1976 by Langcake 
and Pryce [21], leading to the subsequent research about bioactive function of the molecule 
(Figure 1). The scientific literature has reported several benefits related to resveratrol, most of 
them regarding to antioxidant capacity and cardiovascular improvement. However, pharma-
cokinetics of the molecule and the great content on red wine and grapes reveal resveratrol as 
an essential compound on the Mediterranean diet regarding neuroprotection.
Despite several studies regarding pharmacokinetics of resveratrol, it is still uncertain. Many 
scientific researchers have reported excellent values regarding in vitro bioavailability of res-
veratrol [22]. However, these values are not in agreement with in vivo results, mainly due to 
chemical insubstantiality [23]. In fact, revisions about pharmacokinetics differ widely between 
Figure 1. Resveratrol and related metabolites.
Current Topics on Superfoods16
them about bioavailability of resveratrol. Fernández-Mar et al. reviewed knowledge on sci-
entific literature, reporting a bioavailability of resveratrol over 70% [24]. Meanwhile, Ahmed 
et al. found a bioavailability minor than 1% after extensive revision of literature, reflecting the 
high discrepancies about the absorption of resveratrol [23].
Dietary sources of resveratrol comprise a wide variety of plant matrices [23]. Health benefits 
attributed to resveratrol were noticed by the scientific community, leading to the increment of 
scientific reports relating its presence in a wide range of plants. From now, resveratrol has been 
reported to be present in at least 72 plant derived foods [23, 25]. As reported by Fernández-
Mar et al. main sources of resveratrol comprise peanuts, pistachios, different berries, dark 
cocoa, and grapes/wine. All of them could be included in the Mediterranean diet; however, 
the main source of resveratrol in the Mediterranean diet are grape and derivatives, especially 
red wine [26–29]. Thus, concentration of trans-resveratrol in red wine can reach 14.3 mg/L, 
depending on the type of grape, cultivar conditions, or vinification procedures [23, 26–29]. 
Resveratrol is exclusively present in seeds and skin of grapes. Therefore, concentration of 
resveratrol in red wine is higher than white ones, due to the vinification process which leads 
to more extensive contact between skin/seeds and must [24]. As commented above, not only 
resveratrol has been found in grapes and must.
As reviewed by Ahmed et al. [23], resveratrol can also be found in different berries and related 
products, namely blueberries cranberries, bilberries, lingonberries, partridgeberries, mulber-
ries and strawberries [30–32]. However, the different technological and agronomical processes 
applied to berries and the slight content on resveratrol, are limiting factors for considering 
berries as remarkable source of that bioactive compound. Similarly, other foods containing 
minor amounts of resveratrol are dark cocoa, beer, and bee wax from honeycomb [33–39].
Other food with high amount of resveratrol are peanuts, in which resveratrol can be found 
in all edible parts of the plant. For example, peanut butter and peanut oil were found to have 
high quantity of trans-resveratrol reaching 16.9 μg/g in case of peanut oil [36, 37].
Resveratrol has shown different pathways that could postpone neurodegenerative diseases 
onset, especially Alzheimer disease [23]. In 2017, Ahmed et al. published a revision about the 
role of resveratrol in Alzheimer disease and other neurodegenerative diseases. They showed a 
total of 18 recent publications about the different action of resveratrol in human organism [23].
As a summary, resveratrol leads to:
• Inhibition of tauopathy.
• Enhancement of long-term memory formation.
• Inhibition of brain pro-inflammatory responses.
• Inactivation of astrocytes.
• Enhancement of sirtuin-1 activity.
• Protection from oxidative injury.
• Inhibition of neurotoxicity by H
2
O
2
.
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• Inhibition of synthesis of Aβ plaque.
• Prevention of neuronal death.
Cognitive impairment is also susceptible to be treated with resveratrol, as observed in animal 
models. Consequently, resveratrol might also be considered as a potential anti-depressant 
bioactive compound [28].
Neuronal deficiency originates from multiple neurodegenerative diseases. Resveratrol seems 
to be quite associated to the development of specific neurodegenerative diseases as Alzheimer 
disease or Huntington disease and Parkinson disease [29]. The most outstanding capacity of 
resveratrol that influences its effectiveness for the treatment of neurodegenerative diseases is 
the ability to penetrate the blood-brain barrier. In fact, it has demonstrated a great neuropro-
tective capacity, even in administration at low doses.
The activation of sirtuin-1 pathway (SIRT1) seems to be a determinant property of resveratrol 
[40, 41]. Parker et al. [42] showed that by daily intake of one wine glass, it brings enough 
resveratrol (500 nM) to combat neuronal dysfunction caused in Huntington and Alzheimer’s 
diseases through SIRT1 activation.
Regarding Parkinson’s disease, the first advances regarding its relation with resveratrol were 
published in the year 2000 [43]. In mice, Karuppagounder et al. reported that daily intake of 
resveratrol decreased Aβ plaque in the CNS. Mayor changes were observed in the medial 
cortex, the striatum and the hypothalamus. Moreover, the most noticeable changes were 
observed deprived of the sirtuin-1 pathway, which enhances the hypothesis of reduced for-
mation of Aβ plaque due to reduction cysteine and glutathione in the CNS [44].
One of the most studied characteristics of resveratrol is its ability to reduce oxidative injury. 
Reactive oxygen species (ROS) are mayor agents promoted unpaired oxidative stress, and 
are determinant for the production of oxidative injury and non-enzymatic lipid peroxidation. 
Oxidized lipoproteins stimulates apoptosis due to the union of DNA to NF-κB. Resveratrol 
acts inhibiting the activation of NF-κB, which reduces the possibility of oxidative injury at the 
Central Nervous System (CNS) [45, 46].
2.2. Melatonin
Melatonin (N-acetyl-5-methoxytyramine) is a characteristic neurohormone of the pineal 
gland, also produced as a secondary metabolite in plants (Figure 2). It has been shown that 
synthesis of melatonin is produced from tryptophan, serotonin and N-acetylserotonin ulti-
mately. On the other hand, melatonin molecule can also be formed by O-methylation of sero-
tonin followed by N-acetylation of 5-methoxytryptamine in yeast [47, 48].
The absorption of melatonin after oral intake has been previously approached by the sci-
entific literature, reporting similar values between different researchers. Bioavailability 
reported values vary from 33 to 8.7% [49–51]. The absorption of melatonin is delimited by 
many parameters such as age, sex, season or circadian cycle. Nevertheless, there is vari-
ables such as elimination and distribution half-life that look to remains equivalent between 
subjects.
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Nowadays, the claim accepted by the European Food Safety Authority concerning melatonin 
is related to mitigation of subjective feelings of jet lag, reduction of sleep onset latency, and 
contribution to sleep quality. Doses of melatonin for reaching these effects are between 0.5 
Figure 2. Melatonin and related metabolites.
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and 5 mg. Moreover, the effects commented before can occur if the administration of the 
indolamine is close to bed time on the first day [52].
Melatonin were reported in seeds such as rice and sweet corn, besides roots, leaves and fruits 
from different plants. In fact, melatonin has been reported in strawberries, kiwis, pineapples, 
bananas and apples [24]. The presence of melatonin has also been described in olive oil, extra 
virgin olive oil, and in sunflower oil at concentrations between 71 and 113 pg mL−1 [53]. Other 
foods from Mediterranean diet that have sown high concentration of melatonin are salmon 
(3.7 ng g−1), chicken and lamb (2.3 ng g−1 and 1.6 ng g−1 respectively), bread’s crumb and crust 
(341 and 138 pg g−1 respectively) and yogurt (126 pg g−1) [54, 55].
Despite being present in many foods, main sources of Melatonin in Mediterranean diet are 
grapes and especially, wines. Iriti et al. showed variation in the concentration of melatonin 
in different varieties of grapes, such as: Nebbiolo, Croatina, Sangiovese, Merlot, Marzemino, 
Cabernet Franc, Cabernet Sauvignon and Barbera [56]. These authors described a concentra-
tion of melatonin ranging from 0.005 to 0.9 ng g−1. Likewise, Mercolini et al. also observed the 
presence of melatonin in wine (0.4–0.5 ng mL−1) [57].
Recently, other authors have reported melatonin in higher concentration than observed in 
previous reports (245–423 ng mL−1). Rodríguez-Naranjo et al. carried out an investigation in 10 
monovarietal wines: Cabernet Sauvignon, Petit Verdot, Prieto Picudo, Syrah and Tempranillo 
[58]. Despite not found in grapes and musts, melatonin and its isomers were found in finished 
wines derived from them. That fact, revealed that melatonin is formed during wine process-
ing from yeasts.
Melatonin can exert diverse beneficial effects for health, having demonstrated antioxi-
dant, anticancer, immunomodulation and neuroprotective capacity [24]. In addition, 
biological activities of the most important metabolites of melatonin, N-1-Acetyl-N-2-formyl-5-
methoxykynuramine (AFMK) and N-1-Acetyl-5-methoxykynuramine (AMK), have also been 
reported. AFMK is a potent antioxidant, which provides protection to the DNA molecule 
and lipids through different many metabolic pathways. On the other hand, AMK is also a 
powerful antioxidant and is able to inhibit the biosynthesis of prostaglandins by binding to 
diazepam receptors [59–61].
Like other secondary metabolites, melatonin can stimulate endogenous antioxidant enzymes 
and/or capture free radicals (antioxidant capacity in vitro and in vivo) [47, 62, 63]. This neuro-
hormone is capable of capturing reactive oxygen species, such as peroxynitrite [64]; or hydro-
gen peroxide in a dose-dependent manner [61]. In addition, melatonin has demonstrated 
antioxidant capacity in vitro by the ABTS+ method [62]. In vivo studies have also demon-
strated the antioxidant effect of melatonin. When administered in mice, it was observed that 
melatonin is able to reduce chronic oxidative stress related to aging [65], and that it could 
even reduce blood pressure in men with chronic hypertension [66].
The amphipathic nature of the molecule allows it to cross physiological barriers, so its pres-
ence has been described in the nucleus of the cytosol, in the mitochondria and in different 
biological membranes [67]. The importance of this fact lies in the fact that the molecule can 
act in the places where free radicals are formed, providing antioxidant defense from oxidative 
injury where they are needed.
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The role of melatonin as neuroprotective agent is relevant. It has been successfully proved 
in sleep disorders, helping to restore circadian rhythm. Moreover, melatonin is especially 
effective in patients with neurodegenerative diseases [68]. Several scientific studies have been 
carried out with the aim for palliating consequences of diseases such as Alzheimer, Parkinson, 
Huntington disease or amyotrophic lateral sclerosis, obtaining satisfactory results [24].
Miller et al. widely reviewed neuroprotective capacity of melatonin, reporting a wide range of 
actions in the human being [69]. Regarding neurodegenerative diseases, the most susceptible 
to be treated by melatonin are Parkinson disease [70–72], Multiple sclerosis [73, 74], Alzheimer 
disease [75–77] and amyotrophic lateral sclerosis [78–81].
The different effects of melatonin that could be useful for the improvement of neurological 
pathologies are large [69]. Melatonin can improve the evolution of Parkinson disease by the 
reduction of excitotoxicity caused by the autoxidation of dopamine [70], or improving quality 
and length of sleep [72]. Moreover, melatonin protects from injury to mitochondria, decreas-
ing lipid peroxidation in multiple sclerosis and Alzheimer disease [73–75] and increase anti-
oxidant enzymes generation [74]. Melatonin has also showed capacity to protect against 
cognitive deficits and inhibits formation of nicotinamide and Aβ plaque [76–78]. Melatonin 
also is able to reduce oxidative injury by reducing carbonyls formation [79, 80], and delays the 
progression of amyotrophic lateral sclerosis by inhibiting MT1 reception loss [81].
2.3. Hydroxytyrosol
Hydroxytyrosol is also known as 2-(3,4-dihydroxyphenyl)-ethanol (3,4-DHPEA) and as DOPET 
(Figure 3). Hydroxytyrosol is mainly found in olive oil as secoiridoid derivatives, as acetate and 
in free form [82]. Both hydroxytyrosol and its derivatives arise from oleuropein (hydroxytyro-
sol esterified with elenolic acid), present in olives during the extraction of olive oil [24].
Wine has proven to be another important source of hydroxytyrosol in the Mediterranean diet, 
and is formed in wine from tyrosol during alcoholic fermentation. Hydroxytyrosol was firstly 
found in Italian wines by Di Tommaso et al. [83], and later in other Italian and Greek wines 
[84–86]. Some authors describe a higher concentration in red wines (3.66–4.20 mg L−1) than in 
white wines (1.72–1.92 mg L−1) [24, 87]. Finally, Minuti et al. obtained hydroxytyrosol concen-
trations between 1.8 and 3.1 mg L−1 in red wine [87]. Thus, scientific literature shows that wine 
is an important source of hydroxytyrosol in the diet, along with olive oil [24].
De La Torre et al. and Schröder et al. investigated the bioavailability of hydroxytyrosol by com-
paring the intake of red wine and olive oil [87–89]. The intake of red wine (250 mL) increased 
plasmatic concentration of hydroxytyrosol above 8 ng mL−1, representing greater increase than 
the observed after the intake of olive oil (0.35 mg of hydroxytyrosol with the intake of wine 
red and 1.7 mg with the ingestion of olive oil). These authors proposed the endogenous pro-
duction of hydroxytyrosol from ethanol and dopamine in response to the observed increase.
Moreover, tyramine has been proposed as another route for hydroxytyrosol formation, and 
could be partly responsible for the increased endogenous formation of hydroxytyrosol after 
the intake of red wine. Therefore, substantial content of tyramine in red wine, could lead to the 
increase of endogenous formation of hydroxytyrosol. However, the amount of tyramine in the 
red wine is not large enough to explain such increase in endogenous hydroxytyrosol [88].
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Several studies have reported beneficial effects of hydroxytyrosol, mainly after the intake of 
olive oil (the main source of hydroxytyrosol in the Mediterranean diet). The different effects 
attributed to hydroxytyrosol include: antioxidant capacity, cardioprotective effect, anticancer, 
Figure 3. Hydroxytyrosol and related metabolites.
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antimicrobial, neuroprotective and antidiabetic activity [24]. Numerous authors have proved 
their ability both to chelate oxidizing compounds [90, 91], and to increase the concentration 
of antioxidant enzymes [91].
Neurodegenerative diseases, such as Alzheimer’s disease or Parkinson’s disease, could also 
be improved by the ingestion of hydroxytyrosol [92, 93]. As melatonin, hydroxytyrosol has 
the ability to cross the blood–brain barrier. Therefore, it can go through the brain and is rap-
idly metabolized, acting where the oxidative attack is produced [24].
Different studies evaluating the effects of hydroxytyrosol, showed the great neuroprotective 
capacity of the molecule. Hydroxytyrosol considerably inhibits LDL efflux in a dose-depen-
dant way, both in vivo and in vitro. That fact offers an initial knowledge for more studies 
as potential effects of hydroxytyrosol as neuroprotective compound [93]. Marhuenda et al. 
reported a descend on the formation of neuroprostanes and F
2
-dihomo-isoprostanes after the 
intake of red wine [28]. These effect was related to the content on hydroxytyrosol, more than 
other compounds from red wine matrix. Moreover, an oleuropein-enriched extract showed 
neuroprotective capacity by establishing a non-covalent complex with the amyloid–β–pep-
tide, so can be decisive in many neurodegenerative diseases as Alzheimer’s or Parkinson’s 
disease. Therefore, hydroxytyrosol, being the main degradation molecule from oleuropein, 
can be proposed as a promising neuroprotective compound [92].
2.4. Polyphenols
Polyphenols comprises a large and heterogeneous group of phytochemicals containing phe-
nol rings. They are mainly divided into flavonoids, phenolic acids, stilbenes, and lignans. 
Mayor flavonoids are flavones, flavonols, flavanols, flavanones, isoflavones, and anthocya-
nins [94] (Table 1).
Polyphenols can induce antioxidant enzymes such as glutathione peroxidase, catalase and 
superoxide dismutase that decompose hydroperoxides, hydrogen peroxide and superoxide 
anions, respectively. Moreover, they can also inhibit the expression of enzymes such as xan-
thine oxidase [95]. Dietary polyphenols have been shown to play important roles in human 
health. In fact, high intake of fruits, vegetables and whole grains, which are rich in polyphe-
nols, has been related to reduced risk of many chronic diseases including cancer, cardiovas-
cular disease, chronic inflammation and many degenerative diseases [96].
Health benefits of catechins and proanthocyanidins are related to their antioxidant character 
and free radical scavenger activity. Moreover, they can switch mechanisms involved in different 
pathologies such as: hypertension, inflammation, proliferation cellular, thrombogenesis, hyper-
triglycemia, hypercholesterolemia and neurodegenerative diseases or neuroinflammation [94].
Studies conducted on cell cultures stimulated with lipopolysaccharide show that the admin-
istration of quercetin, catechin and epigallocatechin gallate blocks the inflammatory response 
by inhibiting NOSi and the expression of cyclooxygenase (COX-2), as well as the production of 
NO, the release of pro-inflammatory cytokines, and the generation of ROS, in astrocytes and in 
microglia [97]. These extracts of phytochemicals have also been shown to inhibit MAPKs such 
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as p38 or ERK1/2, which regulate NOSi and TNF-α, in addition to the activation of glial cells 
[97]. Mendel et al. suggest that catechins, may protect brain from aging and reduce the incidence 
of dementia, Alzheimer disease and Parkinson disease [98]. Moreover, Geiser et al. indicate that 
both anti-aggregation and antioxidant characteristics of catechins may alter mRNA expression 
to reduce feed-forward mechanisms and promote non-amyloidogenic processing [99].
In vivo studies show that chronic administration of epicatechin in combination with physical 
exercise, improves spatial memory, due to the increase in the Akt protein that activates the 
endothelial nitric oxide synthase (NOSe) enzyme, stimulate the angiogenesis, as well as the 
increase in neuronal density in regions such as the dentate gyrus of the hippocampus [100].
Other group of polyphenols which has showed several benefits are anthocyanins. Several 
studies have shown beneficial effects of anthocyanins on health, and the high antioxidant 
capacity due to their capacity to protect from free radicals by the donation of hydrogen atoms. 
The role of anthocyanins in neurodegenerative diseases is strongly linked to oxidative attack 
protection. Anthocyanins can modulate cognitive and motor function, enhancing memory, 
and preventing age-related decline in neural function [102]. Extracts rich in anthocyanins and 
proanthocyanidins exhibited greater neuroprotective activity than extracts rich in other poly-
phenols. Moreover, many individual anthocyanins interfered with rotenone neurotoxicity, 
which can be related with increased memory [103].
Finally, mayor food containing anthocyanins are berries that can effectively reverse age-
related deficits in certain aspects of working memory. Anthocyanins and other flavonoids 
can prevent neuroinflammation, by the activation of synaptic signaling, and improving blood 
flow to the brain. It appears that some dietary anthocyanins can cross the blood–brain barrier, 
allowing the compounds to have a direct beneficial effect [100]. Anthocyanins suppress mito-
chondrial oxidative stress-induced apoptosis by preserving mitochondrial GSH and inhibit-
ing cardiolipin oxidation and mitochondrial fragmentation [104].
Main food sources
Flavonoids Anthocyanins Cherries, red wine, olives, hazelnuts, almonds, black elderberry, black 
chokeberry, blueberries
Flavonols Grapefruit/pomelo juice, oranges, orange juice, grapefruit juice
Flavanols Dark chocolate red wine, apples, peaches, cocoa powder, nuts, dark 
chocolate
Isoflavones Soy flour, beans soy paste, roasted soy bean,
Flavanones Grapefruit/pomelo juice, oranges, orange juice, grapefruit juice
Flavones Virgin olive oil, oranges, whole grain wheat-flour bread, refined-grain 
wheat-flour bread, whole grain wheat four, black olives
Stilbenes Resveratrol Grapes, red wine, nuts
Phenolic acids Benzoic acid Olives, virgin olive oil, red wine, walnuts, pomegranate juice, red raspberry
Coffee, maize oil, potatoes
Lignans Cinnamic acid Virgin olive oil, whole grain rye flour, bread from whole grain rye flour, 
flaxseed
Table 1. Main food sources of polyphenols [101].
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3. Conclusion
Neurodegenerative diseases are a public health problem and the possibilities of delaying their 
evolution constitute a challenge for research. Considering the relationship between oxidative 
stress and neuroinflammation with neurodegenerative diseases, monitoring a diet rich in bioac-
tive substances with antioxidant activity and polyunsaturated fatty acids of the omega-3 series, 
with a proven antiinflammatory and neuroprotective effect, could slow down the evolution of the 
disease, improve cognitive deterioration, delay the decline of motor symptoms and improve the 
quality of life of patients. An example of this type of diet is the Mediterranean diet, which is char-
acterized by the consumption of fruits, vegetables, legumes, nuts, olive oil, moderate consumption 
of red wine and blue fish that incorporate bioactive substances with beneficial effects on health.
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